Search results
CAR T-Cell therapy revolutionised landscape of cancer treatment: Doctors
Investing.com· 23 hours agoNew Delhi, May 21 (IANS) A 42-year-old man from Bengaluru has successfully achieved "durable...
AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
Pharmaceutical Technology via Yahoo Finance· 18 hours agoEditorial content is independently produced and follows the highest standards of journalistic...
Keeping CAR T Cells Sharp
The Scientist· 21 hours agoResearchers have observed that certain types of CAR T cells are more effective at eradicating cancer. One especially advantageous quality is a...
Earnings call: Adaptimmune outlines afami-cel launch and financials By Investing.com
Investing.com· 6 days agoAdaptimmune Therapeutics PLC (NASDAQ:ADAP), a biotechnology company specializing in T-cell therapy,...
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...
Morningstar· 6 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular ...
ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple...
FOX 23 News Albany· 17 hours agoImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to ...
...IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF...
Morningstar· 5 days agoBreakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor IMDELLTRA Demonstrated Impressive 40% Objective Response Rate, 9.7 Month Median Duration of Response and ...
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
FOX 23 News Albany· 17 hours agoThe study is being conducted through a research partnership with Moffitt Cancer Center.
ADDF invests $5 million in Coya Therapeutics for FTD treatment By Investing.com
Investing.com· 1 day agoCoya Therapeutics, Inc. (NASDAQ:COYA), a biotech firm focusing on regulatory T cell therapies, has...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 6 days agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...